Survivin expression in "low-risk" and "high-risk" myelodysplastic syndromes

Annals of Hematology

Volumn 86, Issue 3, 2007, Pages 185-189

  Gianelli, Umberto ^a   Fracchiolla, Nicola Stefano ^a   Cortelezzi, Agostino ^a   Pellegrini, Caterina ^a   Savi, Federica ^a   Moro, Alessia ^a   Grimoldi, Maria Grazia ^a   Deliliers, Giorgio Lambertenghi ^a   Coggi, Guido ^a,b   Bosari, Silvano ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Centro Interuniversitario di Ricerche Oncologiche   (Italy)

Author keywords

Immunohistochemistry; Myelodysplastic syndromes; Real time RT PCR; Survivin

Indexed keywords

MESSENGER RNA; SURVIVIN;

ARTICLE; BONE MARROW BIOPSY; CANCER RISK; CELL CYCLE PROGRESSION; CONTROLLED STUDY; GENE EXPRESSION PROFILING; HEMATOPOIESIS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MEGAKARYOCYTE; MYELODYSPLASTIC SYNDROME; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; BONE MARROW; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; NEOPLASM PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 33846686544     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-006-0215-0     Document Type: Article

References (29)

1. Aul C, Bowen DT, Yoshida Y (1998) Pathogenesis, etiology and epidemiology of myelodysplastic syndromes. Haematologica 83:71-86
2. Yoshida Y (1993) Hypothesis: Apoptosis may be the mechanism responsible for the premature intramedullary cell death in the myelodysplastic syndrome. Leukemia 7:144-146
3. Greenberg PL (1998) Apoptosis and its role in the myelodysplastic syndrome: Implications for disease natural history and treatment. Leuk Res 22:1123-1136
4. Ambrosini G, Adida C, Sirugo G, Altieri DC (1998) Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting. J Biol Chem 273:11177-11182
5. Altieri DC, Marchisio C (1999) Survivin apoptosis: An interloper between cell death and cell proliferation in cancer. Lab Invest 79:1327-1333
6. Altieri DC (2001) The molecular basis and potential role of survivin in cancer diagnosis and therapy. Trends Mol Med 7:542-547
7. Li F (2003) Survivin study: What is the next wave? J Cell Physiol 197:8-29
8. Ambrosini G, Adida C, Altieri DC (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphomas. Nat Med 3:917-921
9. Fukuda S, Pelus LM (2001) Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34+ cells by hematopoietic growth factors: Implication of survivin expression in normal hematopoiesis. Blood 98:2091-2099
10. Altieri DC (2003) Validating survivin as cancer therapeutic target. Nat Rev Cancer 3:46-54
11. Badran A, Yoshida A, Wano Y, Mutoh M, Imamura S, Yamashita T, Tsutani H, Inuzuka M, Ueda T (2003) Expression of the anti-apoptotic gene survivin in myelodysplastic syndrome. Int J Oncol 22:59-64
12. Yamamoto K, Abe S, Nakagawa Y, Suzuki K, Hasegawa M, Inoue M, Kurata M, Hirokawa K, Kitagawa M (2004) Expression of IAP family proteins in myelodysplastic syndromes transforming to overt leukemia. Leuk Res 28:1203-1211
13. Brunning RD, Bennett JM, Flandrin G, Matutes E, Head D, Vardiman JW, Harris NL (2001) Myelodysplastic syndromes. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds) WHO classification of tumours. Tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon, pp 63-73
14. Greenberg P, Cox C, Le Beau MM, Fenaux P, Morel P, Sanz G, Sanz M, Vallespi T, Hamblin T, Oscier D, Ohyashiki K, Toyama K, Aul C, Mufti G, Bennet J (1997) International Scoring System for Evaluating Prognosis in myelodysplastic syndromes. Blood 89:2079-2088
15. Falleni M, Pellegrini C, Marchetti A, Oprandi B, Buttitta F, Barassi F, Santambrogio L, Coggi G, Bosari S (2003) Survivin gene expression in early stage non-small cell lung cancer. J Pathol 200:620-626
16. LivaK KJ (1997) ABI Prism 7700 Sequence Detection System, User Bulletin 2. Applied Biosystems
17. Clark DM, Lampert IA (1990) Apoptosis is a common histopathological finding in myelodysplasia: The correlate of ineffective hematopoiesis. Leuk Lymphoma 2:415
18. Raza A, Gezer S, Mundle S, Gao XZ, Alvi S, Borok R, Rifkin S, Iftikhar A, Shetty V, Parcharidou A, Lowe JBM, Khan Z, Chaney C, Showel J, Gregory S, Preisler H (1995) Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood 86:268-276
19. Rajapaksa R, Ginzton N, Rott LS, Greenberg PL (1996) Altered oncoprotein expression and apoptosis in myelodysplastic syndrome marrow cells. Blood 88:4275-4287
20. Parker JE, Mufti GJ (2004) The myelodysplastic syndromes: A matter of life or death. Acta Haematol 111:78-99
21. Vardiman JW, Harris NL, Brunning RD (2002) The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 100:2292-2302
22. Jaffe ES, Harris NL, Stein H, Vardiman JW (2001) World Health Organization classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissue. IARC Press, Lyon
23. Bouscary D, Chen YL, Guesnu M, Picard F, Viguier F, Lacombe C, Dreyfus F, Fontenay-Roupie M (2000) Activity of the caspase-3/CPP32 enzyme is increased in "early stage" myelodysplastic syndrome with excessive apoptosis, but caspase inhibition does not enhance colony formation in vitro. Exp Hematol 28:784-791
24. Boudard D, Sordet O, Vasselon C, Berthéas MF, Freyssenet D, Viallet A, Piselli S, Guyotat D (2000) Expression and activity of caspase 1 and 3 in myelodysplastic syndrome. Leukemia 14:2045-2051
25. McKay TR, Bell S, Tenev T, Stoll V, Lopes R, Lemoine NR, McNeish IA (2003) Procaspase 3 expression in ovarian carcinoma cells increases surviving transcription which can be countered with a dominant-negative mutant, survivin T34A; a combination gene therapy strategy. Oncogene 22:3539-3547
26. Kania J, Konturek SJ, Marlicz K, Hahn EG, Konturek PC (2003) Expression of survivin and caspase-3 in gastric cancer. Dig Dis Sci 48:266-271
27. Invernizzi R, Travaglino E, Lunghi M, Klersy C, Bernasconi P, Cazzola M, Ascari E (2004) Survivin expression in acute leukemias and myelodysplastic syndromes. Leuk Lymphoma 45:2229-2237
28. Zhao J, Tenev T, Martins LM, Downward J, Lemoine NR (2000) The ubiquitinproteasome pathway regulates survivin degradation in a cell cycle-dependent manner. J Cell Sci 113:4363-4371
29. Ciechanover A (1998) The ubiquitin-proteasome pathway: On protein death and cell life. EMBO J 17:7151-7160